-
The FDA approved in December two cell-based gene therapies for sickle cell disease. Doctors and medical professionals say the therapies mark major advances in treatment. Black St. Louisans with the disease are hopeful that the approvals of the treatment will be life-changing but are worried about costs, risks and accessibility.
-
Researchers at Washington University have genetically-engineered cells to react to light.By taking light-sensing receptors from the eye — called opsins —…
-
This article first appeared in the St. Louis Beacon, April 03, 2011 - As Dr. Timothy Miller bicycles from his home in Clayton to his lab at the Washington…
-
This article first appeared in the St. Louis Beacon: Studies presented at a recent meeting of the Association for Research in Vision and Ophthalmology and…